XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 89,487 $ 80,958 $ 263,078 $ 238,106
Net investment income (loss) 277 201 885 515
Total revenues 89,764 81,159 263,963 238,621
Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 56,198 52,375 164,045 151,191
Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,371 5,581 16,597 16,630
Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 24,657 21,003 74,117 63,894
Other        
Disaggregation of Revenue [Line Items]        
Revenues 3,261 1,999 8,319 6,391
Operating Segments | Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Revenues 26,089 22,375 78,302 67,993
Net investment income (loss) 187 101 556 278
Total revenues 26,296 22,496 78,920 68,331
Operating Segments | Health Care Benefits | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 24,645 20,989 74,079 63,848
Operating Segments | Health Care Benefits | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,464 1,406 4,285 4,205
Operating Segments | Health Services        
Disaggregation of Revenue [Line Items]        
Revenues 44,064 40,544 127,907 116,801
Net investment income (loss) 0 0 0 0
Total revenues 46,891 43,254 137,697 125,807
Operating Segments | Health Services | Pharmacy network        
Disaggregation of Revenue [Line Items]        
Total revenues 27,981 26,334 83,050 76,358
Operating Segments | Health Services | Mail & specialty        
Disaggregation of Revenue [Line Items]        
Total revenues 17,004 16,318 50,378 47,269
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Total revenues 1,906 602 4,269 2,180
Operating Segments | Health Services | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 44,985 42,652 133,428 123,627
Operating Segments | Health Services | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,906 602 4,269 2,180
Operating Segments | Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Revenues 19,321 18,007 56,826 53,215
Net investment income (loss) (2) (10) (4) (44)
Total revenues 28,872 27,237 85,578 79,881
Operating Segments | Pharmacy & Consumer Wellness | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 22,977 21,084 67,371 61,496
Operating Segments | Pharmacy & Consumer Wellness | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,371 5,581 16,597 16,630
Operating Segments | Pharmacy & Consumer Wellness | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Pharmacy & Consumer Wellness | Other        
Disaggregation of Revenue [Line Items]        
Revenues 526 582 1,614 1,799
Corporate/ Other | Corporate/ Other        
Disaggregation of Revenue [Line Items]        
Revenues 13 32 43 97
Net investment income (loss) 92 110 333 281
Total revenues 105 142 376 378
Corporate/ Other | Corporate/ Other | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Corporate/ Other | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 12 14 38 46
Corporate/ Other | Corporate/ Other | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1 18 5 51
Intersegment Eliminations        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 0 0 0 0
Total revenues (12,400) (11,970) (38,608) (35,776)
Intersegment Eliminations | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues (11,764) (11,361) (36,754) (33,932)
Intersegment Eliminations | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Other        
Disaggregation of Revenue [Line Items]        
Revenues $ (636) $ (609) $ (1,854) $ (1,844)